Skip to content
Screener

Insmed INSM Net Income

Net Income at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$4.89M-102%
United Therapeutics logo
United TherapeuticsUTHR
$333M+7.6%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
-$54.8M-38.8%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$24.71M+189%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.3B-6.8%
Savara logo
SavaraSVRA
-$40.23M-32.3%

Other financials

Income statement

See full
Revenue$425.5M+296%
Gross profit$358.3M+352%
Operating income-$1.5M+99.5%
EPS (diluted)-$0.06+96.5%

Balance sheet

See full
Cash & equivalents$544.8M-57.6%
Total debt$579.9M+0.8%
Total equity$757.5M-39.4%
Total assets$2.1B-15.2%

Cash flow

See full
Operating cash flow-$88.8M+56.8%
CapEx$6.3M+79.6%
Free cash flow-$95.1M+54.5%

Valuation

See full
Market cap$27.16B-4.5%
Enterprise value$27.2B-1.9%
P/S23.9×-47.6×

Profitability

See full
Gross margin83.5%+7.7pp
Operating margin-73.9%-30.6pp
Net margin-76.9%-31.8pp
FCF margin-71%-28.6pp

Returns & leverage

See full
Return on equity-87.2%-27.3pp
Debt / equity0.8×+0.3×
Current ratio3.7×-3.0×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Insmed’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104506-26-000041
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other (expense) income, net(531)453(1,267)585
Loss before income taxes(11,373)(320,443)(173,471)(576,114)
Provision for income taxes1,8691,2433,3342,155
Net loss$(13,242)$(321,686)$(176,805)$(578,269)
Basic and diluted net loss per share$(0.06)$(1.70)$(0.82)$(3.12)
Weighted average basic and diluted common shares outstanding217,352189,302216,415185,104
Net loss$(13,242)$(321,686)$(176,805)$(578,269)
Other comprehensive income (loss):

Item 1C. Consolidated Financial Statements

FAQ

What is Insmed's net income?
Insmed (INSM) reported net income of -$13.24M in Q2 2026.
How has Insmed's net income changed year-over-year?
Insmed's net income increased by 95.9% year-over-year, from -$321.69M to -$13.24M.
What is the long-term trend for Insmed's net income?
Over 4 years (2021 to 2025), Insmed's net income has grown at a 30.9% compound annual growth rate (CAGR), from -$434.65M to -$1.28B.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Insmed's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude